Producto añadido correctamente al carrito.

discount label
H-ILSPFLPL-OH
Ver en 3D

Biosynth logo

H-ILSPFLPL-OH

Ref. 3D-PP49878

1mg
202,00 €
10mg
234,00 €
100mg
412,00 €
Entrega estimada en Estados Unidos, el Viernes 27 de Diciembre de 2024

Información del producto

Nombre:
H-ILSPFLPL-OH
Descripción:

Peptide H-ILSPFLPL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-ILSPFLPL-OH include the following: Human serum amyloid P functions as a negative regulator of the innate and adaptive immune responses to DNA vaccines Y Wang, Y Guo, X Wang, J Huang - The Journal of , 2011 - journals.aai.orghttps://journals.aai.org/jimmunol/article/186/5/2860/762 The adjuvant effects of co-stimulatory molecules on cellular and memory responses to HBsAg DNA vaccination X Du, G Zheng, H Jin, Y Kang , J Wang - The Journal of Gene , 2007 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/jgm.1004 Hemokinin-1 as an adjuvant molecule enhancing humoral and memory responses to HBsAg DNA vaccination X Chen, W Zhang, W Gao, Q Zou , C Feng, H Liu - Viral , 2012 - liebertpub.comhttps://www.liebertpub.com/doi/abs/10.1089/vim.2012.0015 Levamisole is a potential facilitator for the activation of Th1 responses of the subunit HBV vaccination W Zhang, X Du, G Zhao, H Jin, Y Kang , C Xiao, M Liu - Vaccine, 2009 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X09008603 Endoplasmic reticulum targeting sequence enhances HBV-specific cytotoxic T lymphocytes induced by a CTL epitope-based DNA vaccine W Xu, Y Chu , R Zhang, H Xu, Y Wang, S Xiong - Virology, 2005 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0042682205000899 Induction of CTL responses and identification of a novel epitope of hepatitis B virus surface antigens in C57BL/6 mice immunized with recombinant vaccinia viruses S Roh, YK Lee, BY Ahn, K Kim, A Moon - Virus Research, 2001 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168170200002197 Different immunogenicity of H-2 Kb-restricted epitopes in natural variants of the hepatitis B surface antigen R Schirmbeck, W Böhm, N Fissolo - European journal of , 2003 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200324125 Breaking tolerance in hepatitis B surface antigen (HBsAg) transgenic mice by vaccination with cross-reactive, natural HBsAg variants R Schirmbeck, N Dikopoulos, M Kwissa - European journal of , 2003 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200324403 Adjuvants that enhance priming of cytotoxic T cells to a Kb-restricted epitope processed from exogenous but not endogenous hepatitis B surface antigen R Schirmbeck, K Melber, J Reimann - International immunology, 1999 - academic.oup.comhttps://academic.oup.com/intimm/article-abstract/11/7/1093/667756 Similar as well as distinct MHC class I-binding peptides are generated by exogenous and endogenous processing of hepatitis B virus surface antigen R Schirmbeck, J Wild, J Reimann - European journal of , 1998 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1521-4141(199812)28:12%3C4149::AID-IMMU4149%3E3.0.CO;2-D The immunodominant, Ld-restricted T cell response to hepatitis B surface antigen (HBsAg) efficiently suppresses T cell priming to multiple Dd-, Kd-, and Kb-restricted R Schirmbeck, D Stober, S El Kholy, P Riedl - The Journal of , 2002 - journals.aai.orghttps://journals.aai.org/jimmunol/article/168/12/6253/33599 Mafosfamide combine with GMI-HBVac against HBV via Treg depletion in HBV-infected mice Q Lin, Y Zhong, B Wang - 2023 - preprints.orghttps://www.preprints.org/manuscript/202303.0085 A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice P Buchmann, C Dembek, L Kuklick, C Jager - Vaccine, 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X12018610 Hyper-IL-15 suppresses metastatic and autochthonous liver cancer by promoting tumour-specific CD8+ T cell responses L Cheng, X Du , Z Wang, J Ju, M Jia , Q Huang - Journal of , 2014 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168827814004723 Alternative pathways for processing exogenous and endogenous antigens that can generate peptides for MHC class I-restricted presentation J Reimann, R Schirmbeck - Immunological reviews, 1999 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1600-065X.1999.tb01362.x Adjuvant effect of CIA07, a combination of Escherichia coli DNA fragments and modified lipopolysaccharides, on the immune response to hepatitis B virus surface ES Song, SA Park, SH Kim, YJ Cho - FEMS Immunology & , 2007 - academic.oup.comhttps://academic.oup.com/femspd/article-abstract/51/3/496/631551 Dendritic cells pulsed with exogenous hepatitis B surface antigen particles efficiently present epitopes to MHC class I-restricted cytotoxic T cells D Stober<, Z Trobonjaca , J Reimann - European journal of , 2002 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/1521-4141(200204)32:4%3C1099::AID-IMMU1099%3E3.0.CO;2-8 NKT cells provide help for dendritic cell-dependent priming of MHC class I-restricted CD8+ T cells in vivo D Stober, I Jomantaitė, R Schirmbeck - The Journal of , 2003 - journals.aai.orghttps://journals.aai.org/jimmunol/article/170/5/2540/71290 Synthetic innate defense regulator peptide combination using CpG ODN as a novel adjuvant induces long"‘lasting and balanced immune responses CH Yu, ZC Luo , M Li, L Lu, Z Li - Molecular , 2016 - spandidos-publications.comhttps://www.spandidos-publications.com/10.3892/mmr.2015.4581?text=abstract B7-H1 on hepatocytes facilitates priming of specific CD8 T cells but limits the specific recall of primed responses C Wahl, P Bochtler, L Chen , R Schirmbeck, J Reimann - Gastroenterology, 2008 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0016508508009517 Modified alphavirus-vesiculovirus hybrid vaccine vectors for homologous prime-boost immunotherapy of chronic hepatitis B C Chiale , TO Yarovinsky, SW Mason, BR Madina - Vaccines, 2020 - mdpi.comhttps://www.mdpi.com/2076-393X/8/2/279 In Vivo Compartmentalization of Functionally Distinct, Rapidly Responsive Antigen-Specific T-Cell Populations in DNA-Immunized or Salmonella enterica Serovar AC Kirby, M Sundquist, MJ Wick - Infection and immunity, 2004 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/iai.72.11.6390-6400.2004 Low-dose adenovirus vaccine encoding chimeric hepatitis B virus surface antigen-human papillomavirus type 16 E7 proteins induces enhanced E7-specific antibody A Baez-Astacaºa, E Herraez-Hernandez, N Garbi - Journal of , 2005 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.79.20.12807-12817.2005

Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:

Propiedades químicas

MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:

Información de peligrosidad

Número UN:
Cantidad exceptuada (EQ):
Clase:
Frases H:
Frases P:
Prohibido volar:
Información de peligrosidad:
Grupo de empaquetado:
Cantidad limitada (LQ):

Consulta técnica sobre: 3D-PP49878 H-ILSPFLPL-OH

Use el carrito para solicitar presupuestos o pedidos

Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.

* Campos obligatorios
¡Bienvenido a CymitQuimica!Utilizamos cookies para mejorar su visita. No incluimos publicidad.

Consulte nuestra Política de Cookies para obtener más información o ajuste sus preferencias en "Configurar".